Seneca Partners Invests £1.2m in SolasCure

Solventum Acquires Acera Surgical

December 23, 2025

Medical Devices

Solventum (NYSE: SOLV) has completed the acquisition of Acera Surgical, a privately held bioscience company that develops synthetic tissue matrices for regenerative wound care, for $725 million upfront plus up to $125 million in contingent payments. The deal expands Solventum's MedSurg and advanced wound care portfolio with Acera's synthetic electrospun matrix technology; Acera is expected to generate about $90 million in sales in 2025.

Seacoast Capital Invests $30M in SkinCure Oncology

September 24, 2019

Healthcare Services

Seacoast Capital announced a $30 million syndicated growth equity investment in SkinCure Oncology, a Burr Ridge, Illinois-based provider of turnkey image-guided superficial radiation therapy (IG-SRT) services for dermatologists. The non-control capital infusion was used to facilitate a shareholder dividend and to capitalize SkinCure for future growth and national expansion.

CGE Partners and 22C Capital Invest in Aurora Energy Research

October 30, 2020

Data & Analytics

CGE Partners has invested in Aurora Energy Research to support the company's next phase of global growth, with 22C Capital co‑investing and Steve Halliday joining the board as Chairman. The investment backs founder and CEO Dr. John Feddersen and the existing management team to accelerate international expansion, new product development and future M&A; Aurora is an Oxford‑based provider of power and energy market data, analytics, reports and software with c.148 employees.

Catalyst Clinical Research Acquires Aptus Clinical

May 4, 2022

Healthcare Services

Catalyst Clinical Research, a portfolio company of NovaQuest Capital Management, has acquired U.K.-based Aptus Clinical to accelerate Catalyst's European expansion and broaden its oncology and early-phase clinical services. The deal creates a multi-region CRO operating across North America and Europe, increases Catalyst's patient reach by nearly 600 and lifts combined headcount to more than 800.

Court Square Capital Partners and WindRose Health Investors Recapitalize Soleo Health

February 3, 2025

Healthcare Services

Court Square Capital Partners and WindRose Health Investors announced a jointly controlled recapitalization of Soleo Health, a Frisco, Texas-based provider of specialty pharmacy and infusion services. The investment will provide capital to scale Soleo's national footprint (26 pharmacies, 30+ infusion suites) and support growth across all 50 states while partnering with the company's founders and management team.

Sorrento Therapeutics Acquires ACEA Therapeutics

June 1, 2021

Biotechnology

Sorrento Therapeutics completed the acquisition of ACEA Therapeutics, making ACEA a wholly owned subsidiary and issuing Sorrento common stock plus contingent milestone and royalty payments. The deal adds multiple clinical- and preclinical-stage new chemical entities (including abivertinib) to Sorrento's oncology and immunotherapy pipeline and expands its development and manufacturing footprint in China and North America.